This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (45)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Changing Concepts in Diagnosis and Management

Robert C. Lim, Jr, MD; Frederic S. Bongard, MD

Arch Surg. 1984;119(6):637-642.

Abstract
• We studied 86 cases of hepatocellular carcinoma treated between 1968 and 1982. All other liver tumors were excluded. There were 73 male and 13 female patients (average age, 59 years). The most frequent symptoms were pain (73%), weight loss (56%), and increased abdominal girth (23%). The 1-fetoprotein level was elevated in 23 of 32 patients, and the hepatitis B surface antigen was positive in 15 of 36. Significant differences in the hematocrit reading and total bilirubin and total protein levels were found between those patients with resectable and unresectable tumors. Forty-six patients underwent laparotomy, with a resection rate of 48%. There were six right hepatic lobectomies, four left hepatic lobectomies, and 12 trisegmentectomies. The long-term survival in patients who underwent laparotomy and biopsy only was 4.2 months, while those who underwent resection had an average longevity of 18.7 months (the longest was 11.5 years). Using new imaging techniques, the extent of tumor involvement and operability can be determined with greater accuracy. Criteria for resectability include (1) the absence of vena caval occlusion, (2) the lack of spread between lobes, (3) the absence of portal vein obstruction, and (4) the lack of extrahepatic metastasis.

(Arch Surg 1984;119:637-642)

Author Affiliations
From the Department of Surgery, University of California at San Francisco General Hospital.

Footnotes
Accepted for publication Jan 5, 1984.

Read before the 91st annual meeting of the Western Surgical Association, Monterey, Calif, Nov 14, 1983.

Reprint requests to Department of Surgery, San Francisco General Hospital, 1001 Potrero Ave, Ward 3A20, San Francisco, CA 94110 (Dr Lim).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization Analysis : Relationship to Disease Stage, Tumor Size, and Cirrhosis
Wong et al.
Am. J. Pathol. 1999;154:37-43.
ABSTRACT | FULL TEXT  

Perioperative Nutritional Support in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
Fan et al.
NEJM 1994;331:1547-1552.
ABSTRACT | FULL TEXT  

Improved Early Results of Elective Hepatic Resection for Liver Tumors: One Hundred Consecutive Hepatectomies in Cirrhotic and Noncirrhotic Patients
Franco et al.
Arch Surg 1989;124:1033-1037.
ABSTRACT  

Hepatocellular Carcinoma
DI BISCEGLIE et al.
ANN INTERN MED 1988;108:390-401.
ABSTRACT